FDA chief seeks to soothe US biotech fears over drug approval timeline
Commissioner says agency is hiring scientists as industry warns over delays
Related reading
US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
Return of FDA official targeted by Trump allies hits biotech shares
Food and Drug Administration reinstates Vinay Prasad who left agency in July after social media campaign
US drug regulator promotes veteran to quell unrest in top ranks
Elevation of Richard Pazdur expected to improve FDA staff morale and smooth relations with the pharmaceutical industry
Europe races to placate pharma as Donald Trump turns up the pressure
Tariff deals with the US have bought time but investment momentum is elsewhere
US vaccine overhaul unnerves investors as sceptics seize advisory posts
Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments
US regulator to curtail use of primate testing in drug trials
FDA decision aligns with Trump administration’s effort to lower pharma costs by eliminating lab monkey requirement